论文部分内容阅读
本文研究了头颈部癌病人(HNC)的免疫功能.探讨了病人T淋巴细胞表型;淋巴细胞于体外为Lectin活化后,Ⅰa抗原表达能力;在自身混合淋巴细胞反应中,作为应答或刺激细胞的能力以及同正常的粘附抑制细胞(NASC)协同的能力.此外,著者检测了病人血清,观察HNC病人是否有淋巴网状恶性瘤和自身免疫性疾病及病毒病人血清中含有的淋巴细胞毒性抗体.实验共检测18例HNC病人的T细胞.检
This study investigated the immune function of patients with head and neck cancer (HNC), explored the phenotype of T lymphocytes in patients, the ability of lymphocytes to express Ia after activation of Lectin in vitro, and the response of lymphocytes to spontaneous mixed lymphocyte reaction Cell capacity and ability to co-operate with normal adhesion-inhibiting cells (NASC) In addition, the authors examined patient sera to see if HNC patients have lymphatic neoplastic and autoimmune diseases and lymphocytes contained in the patient’s serum Toxicity was detected in 18 HNC patients